Catalent Pharma Solutions, a US specialist in drug delivery technologies, has promoted David Heyens to the new role of President of Catalent Asia Pacific.
Heyens will drive Catalent's growth in the region following the company’s recent expansion into China and will build on the firm's well-established regional operations in Japan, Australia and Singapore.
Aris Gennadios will replace Heyens as President of Catalent Softgel Technologies. He takes responsibility for the global softgel development, delivery and supply business, which has 10 global manufacturing facilities.
Aris Gennadios
Heyens became President of Catalent’s Softgel Technologies business in 2007. Since joining Catalent in 1995, he has held a number of roles, including President of packaging services, Senior Vice President of Global Sales and Marketing, President of North America Softgel Technologies, and General Manager for the Canadian softgel business.
Prior to joining Catalent, Heyens held leadership roles in sales and marketing at Baxter and Procter & Gamble.
Gennadios began his pharmaceutical industry career in 1996 as an R&D scientist in softgel technology. In 2002, he joined Catalent in business development. After holding several business development roles of increasing responsibility, he became General Manager of the company’s Somerset, NJ site.
In 2010, Gennadios became Vice President and General Manager of Catalent’s Rx Softgel Technologies business, and Vice President and General Manager of the overall global Softgel Technologies business in 2012.
